Source: Eur Respir J 2003; 21: 515-522
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Mar J., Rueda J.R., Duran-Cantolla J., Schechter C., Chilcott J.. The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea. Eur Respir J 2003; 21: 515-522

Member's Comments

No comment yet.

Related content which might interest you: Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 The impact of obstructive sleep apnea syndrome in asymptomatic patients to quality of life Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 The importance of sleep position in treatment planning of patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Improving adherence to treatment in patients with obstructive sleep apnoea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 Prolonged symptoms and sleep quality after hospitalization for covid-19 in patients with obstructive sleep apnoea Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome Source: Eur Respir J 2004; 23: 53-60 Year: 2004 Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2003; 22: Suppl. 45, 97s Year: 2003 Does auto-CPAP improve the quality of sleep in obstructive sleep apnoea (OSA)? Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001 PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing Year: 2012 Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016 Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Are patients satisfied with a group approach to sleep studies for obstructive sleep apnoea? Source: Annual Congress 2007 - Quality, sleep and exercise - the ingredients for a perfect life! Year: 2007 Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom Source: Eur Respir J 2007; 30: Suppl. 51, 322s Year: 2007 The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019 CPAP improves chronic cough in patients with obstructive sleep apnoea – a pilot study Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Assessing an auto set trial period for obstructive sleep apnoea patients Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 569s Year: 2004 Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome? Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012